Pharming Q1 EPS $(0.02) Down From $0.01 YoY, Sales $42.54M Down From $46.62M YoY

Benzinga · 05/11/2023 03:20
Pharming (NASDAQ:PHAR) reported quarterly losses of $(0.02) per share. This is a 440 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $42.54 million in sales this quarter. This is a 8.74 percent decrease over sales of $46.62 million the same period last year.